Overview
MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)
Status:
Completed
Completed
Trial end date:
2007-03-01
2007-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Sitagliptin Phosphate
Criteria
Inclusion Criteria:- Patients have Type 2 Diabetes Mellitus and have laboratory results that are within the
values established by the study such as an Hemoglobin A1c (HbA1c) >=7.5% and <=11% and
a Fasting Plasma Glucose (FPG) >=130 mg/dL and <=280 mg/dL
Exclusion Criteria :
- Patients have Type 1 Diabetes Mellitus or required insulin therapy within the past 12
months